Lassen Therapeutics News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at Lassen Therapeutics

• Maria Fardis, Chief Executive Officer and Chairman of the Board
• Lisa Olson, Director
• Matthew Hobson, Director

Popular executive movements at Lassen Therapeutics

• James Swaney, Vice President, Fibrosis and Translational Biology, has left the company  (posted on March 30 2026).
• Andrew Maleki, Head, Corporate Development & Operations, has left the company  (posted on November 10 2025).

Create your alert
to follow the executive moves at Lassen Therapeutics.

Lassen Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Lassen Therapeutics

Social media about Lassen Therapeutics

• Lassen Therapeutics on Wikipedia, Google News & Yahoo Finance
• Lassen Therapeutics on LinkedIn, X (Twitter) & YouTube